C. Parker Gibbs Jr, MD, discusses how to test for p16 and p21 in patients with osteosarcoma.
C. Parker Gibbs
Advertisement
Articles by C. Parker Gibbs
C. Parker Gibbs Jr., MD, discusses the use of cell cycle checkpoint regulators to indicate response to treatment in osteosarcoma.
Advertisement
Latest Updated Articles
Dr. Gibbs on Predicting Response to Treatment in OsteosarcomaPublished: October 21st 2019 | Updated:
Dr. Gibbs on Testing for p16 and p21 in OsteosarcomaPublished: January 23rd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
4
Dr Spencer on First-Line Chemo Selection in Metastatic Pancreatic Adenocarcinoma
5